Ainnova Tech

Website

Ainnova Tech

21 Investors
AI-powered Health Technology
Houston, TX

Ainnova Tech is a health technology startup that utilizes artificial intelligence for the early detection of systemic diseases through retinal scanning. The company's primary goal is to make preventive medicine more accessible and accurate by integrating its AI-powered diagnostic platform into routine primary care.

Products & Team

VisionAI

AI Diagnostic SoftwareSeed

VisionAI is a cutting-edge, AI-driven web platform that analyzes fundus eye test images for the rapid and accurate detection of diabetic retinopathy and other retinal and systemic diseases. It is designed to be user-friendly and integrate seamlessly into various healthcare settings, providing actionable risk reports within seconds.

Value Proposition

VisionAI addresses the challenge of late disease diagnosis by providing a fast, accessible, and non-invasive tool for early screening. This enables healthcare providers to identify potential health risks much earlier, facilitating timely intervention and improving long-term patient outcomes.

Pain Points

Ainnova addresses the clinical and financial burdens of late-stage disease diagnosis, the high cost of traditional diagnostic equipment, and the general lack of accessible, large-scale preventive screening tools in primary care.

Detects diabetic retinopathy and markers for cardiovascular disease, Alzheimer's, chronic kidney disease, and more.Provides risk analysis and reports in seconds from a non-invasive test.Functions as a web-based platform compatible with any fundus camera on the market.Engineered for use by healthcare professionals in diverse settings, including primary care and pharmacies.
Industry
Other Technology
Primary business sector
Founded
2025
Year established
Location
Houston, TX
Primary headquarters

Funding History

Total Raised:
$2.8M
E

Equity Offering

January 2022
$10.0M
Target
Progress
28%
Raised
$2.8M
Target
$10.0M
#000147793225006257